Yumanity Therapeutics Overview
- Founded
- 2014
- Status
- Public
- Employees
- 48
- Stock Symbol
- YMTX
- Investments
- 1
- Share Price
- $1.06
- (As of Monday Closing)
Yumanity Therapeutics General Information
Description
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.
Contact Information
- 40 Guest Street
- Suite 4410
- Boston, MA 02135
- United States
Yumanity Therapeutics Timeline
Yumanity Therapeutics Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.06 | $1.13 | $1.06 - $19.90 | $11.6M | 10.3M | 86.4K | -$6.44 |
Yumanity Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|
EV | 82,815 | 171,611 | |
Revenue | 10,870 | 6,896 | 0 |
EBITDA | (63,010) | (54,789) | (29,473) |
Net Income | (65,757) | (57,487) | (31,209) |
Total Assets | 69,821 | 114,835 | 17,606 |
Total Debt | 30,141 | 35,289 | 15,220 |
Yumanity Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Yumanity Therapeutics‘s full profile, request access.
Request a free trialYumanity Therapeutics Comparisons
Industry
0000 000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialYumanity Therapeutics Competitors (43)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SAGE Therapeutics | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
000000000 00000000 | Private Equity-Backed | San Diego, CA | 000 | 00000 | 0000000 0000 | 00000 |
0000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
0000 | Venture Capital-Backed | San Diego, CA | 00 | 00.000 | 0000000000 0 | |
000000000000 | Venture Capital-Backed | Clarksville, MD | 0 | 00.000 | 000000 0 |
Yumanity Therapeutics Patents
Yumanity Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020245349-A1 | Compounds and uses thereof | Pending | 22-Mar-2019 | 0000000000 | |
CA-3134510-A1 | Compounds and uses thereof | Pending | 22-Mar-2019 | 0000000000 | |
AU-2020212034-A1 | Compounds and uses thereof | Pending | 24-Jan-2019 | 0000000000 | |
CA-3127791-A1 | Compounds and uses thereof | Pending | 24-Jan-2019 | 0000000000 | |
US-20210139471-A1 | Compounds and uses thereof | Pending | 24-Jan-2019 | C07D413/14 |
Yumanity Therapeutics Executive Team (13)
Yumanity Therapeutics Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
Cecil Pickett Ph.D | Yumanity Therapeutics | Board Member | 000 0000 |
David Arkowitz | Self | Board Member | 000 0000 |
Jeffery Kelly Ph.D | Self | Board Member | 000 0000 |
Kimberlee Drapkin | Self | Board Member | 000 0000 |
Lynne Zydowsky Ph.D | Yumanity Therapeutics | Board Member | 000 0000 |
Yumanity Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialYumanity Therapeutics Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Yumanity Therapeutics‘s full profile, request access.
Request a free trialYumanity Therapeutics Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000000 | 22-Dec-2020 | 0000000000 | Drug Discovery | 0000000 0 |